Your browser doesn't support javascript.
loading
Two types of BCR interactions are positively selected during leukemia development in the Eµ-TCL1 transgenic mouse model of CLL.
Iacovelli, Stefano; Hug, Eva; Bennardo, Sara; Duehren-von Minden, Marcus; Gobessi, Stefania; Rinaldi, Andrea; Suljagic, Mirza; Bilbao, Daniel; Bolasco, Giulia; Eckl-Dorna, Julia; Niederberger, Verena; Autore, Francesco; Sica, Simona; Laurenti, Luca; Wang, Hongsheng; Cornall, Richard J; Clarke, Stephen H; Croce, Carlo M; Bertoni, Francesco; Jumaa, Hassan; Efremov, Dimitar G.
Afiliação
  • Iacovelli S; Molecular Hematology, International Centre for Genetic Engineering and Biotechnology, Rome, Italy;
  • Hug E; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany;
  • Bennardo S; Molecular Hematology, International Centre for Genetic Engineering and Biotechnology, Rome, Italy;
  • Duehren-von Minden M; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany;
  • Gobessi S; Molecular Hematology, International Centre for Genetic Engineering and Biotechnology, Rome, Italy;
  • Rinaldi A; Lymphoma and Genomics Research Program, IOR Institute of Oncology Research, Bellinzona, Switzerland;
  • Suljagic M; Molecular Hematology, International Centre for Genetic Engineering and Biotechnology, Rome, Italy;
  • Bilbao D; European Molecular Biology Laboratory, Rome, Italy;
  • Bolasco G; European Molecular Biology Laboratory, Rome, Italy;
  • Eckl-Dorna J; Department of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria;
  • Niederberger V; Department of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria;
  • Autore F; Department of Hematology, Catholic University Hospital "A. Gemelli," Rome, Italy;
  • Sica S; Department of Hematology, Catholic University Hospital "A. Gemelli," Rome, Italy;
  • Laurenti L; Department of Hematology, Catholic University Hospital "A. Gemelli," Rome, Italy;
  • Wang H; Laboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD;
  • Cornall RJ; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom;
  • Clarke SH; Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC;
  • Croce CM; The Ohio State University Comprehensive Cancer Center, Columbus, OH;
  • Bertoni F; Lymphoma and Genomics Research Program, IOR Institute of Oncology Research, Bellinzona, Switzerland; IOSI Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; and.
  • Jumaa H; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany; Institute of Immunology, University Clinics Ulm, Ulm, Germany.
  • Efremov DG; Molecular Hematology, International Centre for Genetic Engineering and Biotechnology, Rome, Italy;
Blood ; 125(10): 1578-88, 2015 Mar 05.
Article em En | MEDLINE | ID: mdl-25564405
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Leucemia Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos B / Leucemia Linfocítica Crônica de Células B Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Blood Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Leucemia Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos B / Leucemia Linfocítica Crônica de Células B Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Blood Ano de publicação: 2015 Tipo de documento: Article